The Ahmedabad-based company, however, remains listed on the BSE and NSE
Lincoln Pharmaceuticals has de-listed its shares from Ahmedabad Stock Exchange Limited (ASEL), the company said today.
Pursuant to the application made by the company to ASEL for voluntary de-listing of its equity shares, ASEL has granted approval and accordingly the shares of the company stand de-listed from ASEL with effect from November 24, 2016, Lincoln Pharmaceuticals said in a BSE filing.
The Ahmedabad-based company remains listed on the BSE and NSE.